Pure Global

Muscular Dystrophy Newborn Screening Test

Muscular Dystrophy Newborn Screening Test is a medical device type in the Clinical Chemistry specialty. This page includes real-world medical device registration data worldwide for this device type, with registrations from US FDA, Brazil ANVISA, and other global markets.

View regulatory classifications, recent 510(k) clearances, active device registrations, and similar products registered globally under this device category. Pure Global AI's free directory provides comprehensive worldwide registration intelligence across 7,000+ medical device types and 21 specialties.

Global Registration Data
Multi-Country Intelligence
Muscular Dystrophy Newborn Screening Test
Clinical Chemistry Medical Device Type
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Regulatory Classifications

US Regulatory Classifications

QJE

View Product Code Classification

Class 2

21 CFR 862.1506

View CFR Regulation

Clinical Chemistry

Device Characteristics

No

No

No

Not Eligible

Definition

A muscular dystrophy newborn screening test is intended to measure creatine kinase levels obtained from dried blood spot specimens on filter paper from newborns as an aid in screening newborns for muscular dystrophy.